Literature DB >> 17301129

Stability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor binding.

J Billington1, T P Hickling, G H Munro, C Halai, R Chung, G G Dodson, R S Daniels.   

Abstract

Stable trimeric forms of human immunodeficiency virus recombinant gp140 (rgp140) are important templates for determining the structure of the glycoprotein to assist in our understanding of HIV infection and host immune response. Such information will aid the design of therapeutic drugs and vaccines. Here, we report the production of a highly stable and trimeric rgp140 derived from a HIV type 1 (HIV-1) subtype D isolate that may be suitable for structural studies. The rgp140 is functional in terms of binding to CD4 and three human monoclonal antibodies (17b, b12, and 2G12) that have broad neutralizing activities against a range of HIV-1 isolates from different subtypes. Treatment of rgp140 with protein disulfide isomerase (PDI) severely restricted 17b binding capabilities. The stable nature of the rgp140 was due to the lack of processing at the gp120/41 boundary and the presence of an intermonomer disulfide bond formed by the cysteines of the V3 loop. Further characterization showed the intermonomer disulfide bond to be a target for PDI processing. The relevance of these findings to the roles of the V3 domain and the timing of PDI action during the HIV infection process are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301129      PMCID: PMC1900172          DOI: 10.1128/JVI.02138-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  93 in total

Review 1.  HIV-1 attachment: another look.

Authors:  S Ugolini; I Mondor; Q J Sattentau
Journal:  Trends Microbiol       Date:  1999-04       Impact factor: 17.079

2.  Processing and routage of HIV glycoproteins by furin to the cell surface.

Authors:  M Moulard; S Hallenberger; W Garten; H D Klenk
Journal:  Virus Res       Date:  1999-03       Impact factor: 3.303

Review 3.  HIV entry and its inhibition.

Authors:  D C Chan; P S Kim
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

4.  A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.

Authors:  C D Rizzuto; R Wyatt; N Hernández-Ramos; Y Sun; P D Kwong; W A Hendrickson; J Sodroski
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

5.  The crystal structure of the SIV gp41 ectodomain at 1.47 A resolution.

Authors:  Z N Yang; T C Mueser; J Kaufman; S J Stahl; P T Wingfield; C C Hyde
Journal:  J Struct Biol       Date:  1999-06-15       Impact factor: 2.867

6.  Expression and detection of macrophage-tropic HIV-1 gp120 in the brain using conformation-dependent antibodies.

Authors:  R Altmeyer; E Mordelet; M Girard; C Vidal
Journal:  Virology       Date:  1999-07-05       Impact factor: 3.616

7.  The furin protease cleavage recognition sequence of Sindbis virus PE2 can mediate virion attachment to cell surface heparan sulfate.

Authors:  W B Klimstra; H W Heidner; R E Johnston
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  HIV/SIV glycoproteins: structure-function relationships.

Authors:  N W Douglas; G H Munro; R S Daniels
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

9.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.

Authors:  P D Kwong; R Wyatt; J Robinson; R W Sweet; J Sodroski; W A Hendrickson
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

10.  The antigenic structure of the HIV gp120 envelope glycoprotein.

Authors:  R Wyatt; P D Kwong; E Desjardins; R W Sweet; J Robinson; W A Hendrickson; J G Sodroski
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

View more
  7 in total

1.  Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41.

Authors:  Avraham Ashkenazi; Mathias Viard; Yael Wexler-Cohen; Robert Blumenthal; Yechiel Shai
Journal:  FASEB J       Date:  2011-03-23       Impact factor: 5.191

Review 2.  Structure-based vaccine design in HIV: blind men and the elephant?

Authors:  Robert Pejchal; Ian A Wilson
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

3.  Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin.

Authors:  Iman Azimi; Lisa J Matthias; Rob J Center; Jason W H Wong; Philip J Hogg
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

4.  HIV-host interactome revealed directly from infected cells.

Authors:  Yang Luo; Erica Y Jacobs; Todd M Greco; Kevin D Mohammed; Tommy Tong; Sarah Keegan; James M Binley; Ileana M Cristea; David Fenyö; Michael P Rout; Brian T Chait; Mark A Muesing
Journal:  Nat Microbiol       Date:  2016-05-23       Impact factor: 17.745

5.  Mapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomerase.

Authors:  Marie-Jeanne Papandréou; Rym Barbouche; Régis Guieu; Santiago Rivera; Jacques Fantini; Michel Khrestchatisky; Ian M Jones; Emmanuel Fenouillet
Journal:  J Biol Chem       Date:  2010-03-04       Impact factor: 5.157

6.  Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection.

Authors:  Tzanko S Stantchev; Mark Paciga; Carla R Lankford; Franziska Schwartzkopff; Christopher C Broder; Kathleen A Clouse
Journal:  Retrovirology       Date:  2012-12-03       Impact factor: 4.602

7.  A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.

Authors:  Lydia R Meador; Sarah A Kessans; Jacquelyn Kilbourne; Karen V Kibler; Giuseppe Pantaleo; Mariano Esteban Roderiguez; Joseph N Blattman; Bertram L Jacobs; Tsafrir S Mor
Journal:  Virology       Date:  2017-04-28       Impact factor: 3.616

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.